当前位置: X-MOL 学术Ann. Hepatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The liver in times of COVID-19: What hepatologists should know.
Annals of Hepatology ( IF 3.8 ) Pub Date : 2020-05-18 , DOI: 10.1016/j.aohep.2020.05.001
Ezequiel Ridruejo 1 , Alejandro Soza 2
Affiliation  

The ongoing pandemic of coronavirus disease 2019 (COVID-19) pandemic poses a serious threat to healthcare systems globally. Information regarding how the infection affects the liver and relevance of pre-existing liver disease as a risk factor for acquiring the infection or having a severe disease are still scarce. Also, considerations in liver transplant patients, those having hepatocellular carcinoma or under immunosuppressive therapy are being matter of analysis as information is being generated. Different treatments for COVID-19 are currently under study, some of which may be associated to hepatotoxicity. In the present review we discuss current data on the COVID-19 and liver, aiming to provide hepatologists with updated information to face this pandemic.



中文翻译:

COVID-19时代的肝脏:肝病学家应了解的知识。

持续的2019年冠状病毒病大流行(COVID-19)大流行对全球医疗系统构成了严重威胁。仍然缺乏有关感染如何影响肝脏以及先前存在的肝病作为获得感染或患有严重疾病的危险因素的相关性的信息。同样,在肝移植患者,患有肝细胞癌或接受免疫抑制治疗的患者中,考虑到正在生成信息,因此也需要进行分析。目前正在研究COVID-19的不同治疗方法,其中一些可能与肝毒性有关。在本综述中,我们讨论了有关COVID-19和肝脏的最新数据,旨在为肝病专家提供面对这一大流行病的最新信息。

更新日期:2020-05-18
down
wechat
bug